Investigating the Effectiveness and Safety of Combining Thrombopoietin Receptor Agonist and Immunosuppressant Drugs for Patients with Multirefractory Immune Thrombocytopenia after Second-Line Monotherapy Treatments

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Blood

Topics

Biology

Internal Medicine

Physics

Medicine

Hematology

Show all topics

DOI

10.1182/blood-2024-201847